Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial

American Journal of Psychiatry, Ahead of Print.

Source: American Journal of Psychiatry - September 23, 2021 Category: Psychiatry Authors: Joseph R. Calabrese Suresh Durgam Andrew Satlin Kimberly E. Vanover Robert E. Davis Richard Chen Susan G. Kozauer Sharon Mates Gary S. Sachs Source Type: research